| 07:55–08:55 Cubex A1 + A2 |
Breakfast & INDUSTRY SYMPOSIUM |
| 09:00–10:00 Cubex A1 + A2 |
WELCOME Vladimir Tesar PATIENT PANEL: What do patients want? Moderators: Louise Oni, Jonathan Barratt |
| 10:00–11:00 Cubex A1 + A2 |
PLENARY SESSION 1: IgAN Natural History Chairs: Hong Zhang, Bruce A. Julian Suceena Alexander: Asia Chee Kay Cheung: Europe John Sim: North America |
| 11:00–11:30 |
Coffee break |
| 11:30–11:50 Cubex A1 + A2 |
PLENARY SESSION 2: IIGANN Research Group Lecture 1 Chair: Keiichi Matsuzaki Sean Barbour: Risk prediction: What is on the Horizon? |
| 11:50–13:00 Cubex A1 + A2 |
FREE COMMUNICATIONS Cheng-Hsu Chen: Distinct Breath Volatile Organic Compound Signatures Differentiate IgA Nephropathy from Non-IgA Chronic Kidney Disease: A Novel Non-Invasive Diagnostic Approach Ming Li: The CARD9 S12N mutation is associated with an increased risk of IgA nephropathy in Han Chinese Linlin Xu: Genome-wide survival study identified variants associated with disease progression in IgA nephropathy Izabella Z. A. Pawluczyk: Expression of MiR Triplet -192,-194,-215 in IgA Nephropathy: a Pilot Study Beatriz Cortez Ferreira: Morphometric prediction of kidney survival in IgA Nephropathy Ian S. D. Roberts: Glomerular C3 staining at baseline is an independent predictor of renal survival and eGFR loss in the UK National Registry of Rare Kidney Diseases (RaDaR) IgA nephropathy cohort |
| 13:00–14:00 Cubex A1 + A2 |
Lunch & INDUSTRY SYMPOSIUM |
| 14:00–15:00 Cubex A1 + A2 |
PLENARY SESSION 3: IgAN Pathogenesis 1 Chairs: Jan Novak, Jenny Nyström Krzysztof Kiryluk: What has genetics told us about IgAN? Hitoshi Suzuki: What is in an Immune complex in IgAN? James Gleeson: Where does pathogenic IgA come from? |
| 15:00–15:30 Cubex A1 + A2 |
FREE COMMUNICATIONS Kei Ogiwara: Bruton's tyrosine kinase modulates expression of C1GALT1 and production of galactose-deficient IgA1 in IgA nephropathy Yusuke Fukao: Plasmacytoid dendritic cells modulate the pathogenesis of IgA nephropathy by facilitating aberrantly glycosylated IgA synthesis Yu-Ling Chou: Differential nephritogenic levels of human IgG autoantibody containing immune complexes in IgA nephropathy |
| 15:30–16:00 |
Coffee break |
| 16:00–17:00 Cubex A1 + A2 |
AFTERNOON INDUSTRY SYMPOSIUM |
| 18:00–22:00 |
Speakers’ Dinner |
Last update on 22 July 2025.
The programme might be subject to necessary changes.
